{"slug": "openai-uses-nearly-2000-ai-agents-to-analyze-brain-crispr-data-in-32-minutes", "title": "OpenAI uses nearly 2,000 AI agents to analyze brain CRISPR data in 32 minutes", "summary": "OpenAI, PerturbAI and Scripps Research announced on October 21, 2026 that nearly 2,000 GPT-Rosalind AI agents analyzed PerturbAI's 8-million-cell mouse brain CRISPR atlas in 32 minutes, a task projected to take human experts several months to a year. The distributed agents cited more than 700 references versus 11 for a single agent, and blinded specialists preferred the multi-agent outputs 75% of the time. The agents surfaced a new hypothesis linking DCTN1 disruption to altered neuronal cholesterol regulation relevant to Perry syndrome, plus unexpected differences between Tsc1 and Tsc2 disruption in movement-related brain regions; the findings still require experimental validation and the bioRxiv preprint needs peer review.", "body_md": "OpenAI / Wikimedia Commons (Public domain)\n\n# OpenAI uses nearly 2,000 AI agents to analyze brain CRISPR data in 32 minutes\n\nA swarm of GPT-Rosalind agents worked through an 8-million-cell mouse brain atlas and surfaced a possible new drug target for neurodegenerative disease\n\n[OpenAI](https://cryptobriefing.com/markets/openai/) pointed nearly 2,000 AI agents at a massive mouse brain dataset. They finished their analysis in 32 minutes.\n\nHuman experts were projected to need anywhere from several months to a year for the same job. The agents also flagged a potential new drug target for neurodegenerative disease.\n\n## What the agents actually did\n\nThe project, announced on October 21, 2026, was a collaboration between OpenAI, PerturbAI and Scripps Research. The agents ran on OpenAI’s GPT-Rosalind system.\n\nTheir target was PerturbAI’s CRISPR atlas. It covers 8 million mouse brain cells and nearly 2,000 genes linked to disease.\n\nThe agents examined how cells responded to each gene disruption, then cross-referenced those responses against the existing scientific literature.\n\nThe result is what the team calls a reasoning atlas. It ties gene effects and cellular responses to established research, essentially layering an annotated explanation over raw data.\n\nThe reasoning atlas has been made publicly available.\n\n## Many agents beat one\n\nThe distributed agents cited more than 700 references. The single agent cited 11.\n\n### AI, tech, and the markets they move—in one daily briefing.\n\nDaily. Free. Join 34,000+ readers across crypto, finance, and policy.\n\nIn blinded reviews, specialists preferred the multi-agent outputs 75% of the time over the single-agent versions.\n\n## The findings that stood out\n\nThe first involved two genes called Tsc1 and Tsc2. The agents found unexpected differences between how disrupting each gene affected movement-related regions of the brain, including the cerebellum. Those genes are relevant to tuberous sclerosis.\n\nThe second finding is tied to drug discovery. The agents generated a new hypothesis linking disruptions in a gene called DCTN1 to altered cholesterol regulation in neurons.\n\nThat connection matters for Perry syndrome. It is a neurodegenerative condition that resembles Parkinson’s disease, and cholesterol handling in neurons is considered a critical factor in it.\n\n## How we got here\n\nThe project grew out of a year-long collaboration between OpenAI and PerturbAI.\n\nPerturbAI first released its CRISPR atlas publicly in March 2026. Since then, it has been downloaded more than 40,000 times.\n\nThe teams have also shared a preprint on bioRxiv.\n\n## What this means for drug discovery and AI\n\nThe results open the door to potential joint drug-target discovery efforts using PerturbAI’s in vivo datasets.\n\nThe findings still need experimental validation, the preprint still needs peer review, and a 75% expert preference rate also means reviewers favored the single agent a quarter of the time.\n\n**Disclosure:** This article was edited by Diego Almada Lopez. For more information on how we create and review content, see our\n\n[Editorial Policy](https://cryptobriefing.com/editorial-policy/).", "url": "https://wpnews.pro/news/openai-uses-nearly-2000-ai-agents-to-analyze-brain-crispr-data-in-32-minutes", "canonical_source": "https://cryptobriefing.com/openai-ai-agents-brain-crispr-atlas/", "published_at": "2026-10-21 14:13:47+00:00", "updated_at": "2026-10-21 14:43:55.890687+00:00", "lang": "en", "topics": ["artificial-intelligence", "ai-agents", "ai-research", "large-language-models", "ai-safety"], "entities": ["OpenAI", "PerturbAI", "Scripps Research", "GPT-Rosalind", "Tsc1", "Tsc2", "DCTN1", "Perry syndrome"], "also_reported_by": [], "alternates": {"html": "https://wpnews.pro/news/openai-uses-nearly-2000-ai-agents-to-analyze-brain-crispr-data-in-32-minutes", "markdown": "https://wpnews.pro/news/openai-uses-nearly-2000-ai-agents-to-analyze-brain-crispr-data-in-32-minutes.md", "text": "https://wpnews.pro/news/openai-uses-nearly-2000-ai-agents-to-analyze-brain-crispr-data-in-32-minutes.txt", "jsonld": "https://wpnews.pro/news/openai-uses-nearly-2000-ai-agents-to-analyze-brain-crispr-data-in-32-minutes.jsonld"}}